After hours movers are the stocks bought and sold in an after-hours market. The after-hours market opens at 4 p.m. U.S. Eastern Time following the close of the major U.S. stock exchanges. It is possible for after-hours trading to continue until 8 p.m., but the volume usually dwindles much earlier for the aftermarket movers. Electronic communication networks (ECNs) are used for trading in the after-hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Sponsored
When news breaks after the stock exchange close, after-market movers can be used by traders or investors. Sometimes, news, such as earnings announcements, may trigger aftermarket movers to act.
After-hours movers Stock may experience a spike in volume on the initial release of news, but it usually diminishes as the session advances. By 6 p.m., the volume slows down significantly. Illiquid stocks are risky to trade after business hours.
Unlike the billions of shares traded during normal business hours, after-hours sessions trade a tiny fraction of that level. Is it possible to make money trading in an after-hours market? It’s possible, but you need to do your homework first.
In this article, we are presenting you the 5 best aftermarket movers to invest in right now.
AnPac Bio-Medical Science Co. Ltd. (ANPC)
AnPac Bio-Medical Science Co. Ltd. (ANPC) shares were rising 36.99% to trade at $0.23 in after-hours at the last check. ANPC’s stock gained 0.72% to close Wednesday’s session at $0.17. The stock volume remained at 0.67 million shares, which was lower than the average daily volume of 3.17 million shares within the past 50 days. ANPC shares have fallen by -94.31% over the last 12 months, and they have moved up by 3.71% in the past week. Over the past three months, the stock has lost -41.56%, while over the past six months, it has shed -65.73%. Further, the company has a current market of $4.12 million and its outstanding shares stood at 25.22 million.
If we take a glance at the Ownership summary of AnPac Bio-Medical Science Co. Ltd.’s stock, Institutional holders make up 2.20% of its total stock ownership. Altogether, they are the legal holders of 25.22 million shares. Whilst focusing on the top 3 stockholders for this publicly-traded organization, Citadel Securities LLC owns 0.37 million shares, with Citadel Advisors LLC in 2nd place owning 0.37 million shares and PNC Bank, (Investment Management) in third place with total ownership of 0.12 million shares.
Immunic Inc. (IMUX)
Immunic Inc. (IMUX) has advanced 17.99% at $11.41 in after-hours trading hours on the last check Wednesday. The stock of IMUX gained 2.76% to complete the last trading session at $9.67. The price range of the company’s shares was between $7.5701 and $9.79. It traded 21.81 million shares, which was above its daily average of 1.48 million shares over 100 days. IMUX’s shares have gained by 167.87% in the last five days, while they have added 134.14% in the last month. Further, it is currently trading at a price-to-book ratio of 2.29.
H.C. Wainwright rated the Immunic Inc. (NASDAQ: IMUX) stock “a Buy”. H.C. Wainwright’s estimates were contained in a research note released on Monday, September 19, 2022. Several other experts on Wall Street have posted such reports regarding IMUX shares. According to Aegis Capital, the stock is “a Buy,”$55. Aegis Capital published its figures in a research note released to investors on Thursday, April 15, 2021. Other experts at JMP Securities have the stock’s price target at $55 price; with their rating of the stock as “an Mkt outperform.”. These scores were published in a research note the firm released on Wednesday, March 24, 2021.
Petros Pharmaceuticals Inc. (PTPI)
At last check in after-hours trading, shares of Petros Pharmaceuticals Inc. (PTPI) were up 15.72% at $0.48. PTPI’s stock closed the last session at $0.41, decreasing -1.29% or -$0.01. Shares of the company fluctuated between $0.39 and $0.48 throughout the day. The number of shares exchanged was 46186.0, less than the company’s 50-day daily volume of 0.13 million and lower than its Year-to-date volume of 1.08 million. In the past 12 months, the company’s stock has advanced by -73.75%, and in the last week, the stock has moved down -13.60%. For the last six months, the stock has lost a total of -62.96%, and over the last three months, the stock has decreased by -51.20%. The stock has returned -87.54% so far this year.
Volatility is just a proportion of the anticipated day-by-day value extension—the range where an informal investor works. Greater instability implies more noteworthy benefit or misfortune. After an ongoing check, Petros Pharmaceuticals Inc. (NASDAQ: PTPI) stock is found to be 14.82% volatile for the week, while 13.36% volatility is recorded for the month. The outstanding shares have been calculated at 20.68M. Based on a recent bid, its distance from the 20-day simple moving average is -20.51%, and its distance from the 50-day simple moving average is -35.42% while it has a distance of -64.61% from the 200-day simple moving average.
Smart for Life Inc. (SMFL)
Smart for Life Inc. (SMFL) shares have gained 5.00% at $0.3467 in Wednesday’s after-hours session. Smart for Life Inc.’s stock subtracted -9.34% to finish the last trading session at $0.33. The stock recorded a trading volume of 86858.0 shares. The shares of Smart for Life Inc. have advanced -21.83% in the last five days; however, they have lost -43.92% over the last month. The stock price has shed -25.78% over the last three months. Additionally, it has a price-to-sales ratio that stands at 0.69.
Altbach Ronald S., Director, of Smart for Life Inc. (SMFL), sold 888 shares of Smart for Life Inc. stock in an exchange that took place on Jun 09. The shares were sold at an average price of 0.44 each, amounting to a total Sale worth $394. As of the close of the Sale, Director now directly holds 249,112 shares of the organization’s stock, which is now worth about $82206.96. The deal was disclosed in a Securities & Exchange Commission legal filing, which can be publicly viewed on the SEC website.
National CineMedia Inc. (NCMI)
National CineMedia Inc. (NCMI) is rising on the charts today, up 7.20% to trade at $0.551 at last check in after-hours trading. On Wednesday, shares in National CineMedia Inc. rise 6.18% to close the day at $0.51. The volume of shares traded was 1.24 million, which is higher than the average volume over the last three months of 969.25K. During the trading session, the stock oscillated between $0.4905 and $0.57. The company had an earnings-per-share ratio of -0.40. NCMI’s stock has lost -9.51% of its value in the previous five sessions and -51.05% over the past one month but has lost -81.71% on a year-to-date basis. The stock’s 50-day moving average of $1.1293 is above the 200-day moving average of $1.8487. Moreover, the stock is currently trading at an RSI of 24.15.
Looking at the support for the NCMI, a number of firms have released research notes about the stock. B. Riley Securities stated their Neutral rating for the stock in a research note on October 12, 2022, with the firm’s price target at $1-$0.50. B. Riley Securities coverage for the National CineMedia Inc. (NCMI) stock in a research note released on June 21, 2022, offered a Neutral rating with a price target of $1.50. B. Riley Securities coverage for the National CineMedia Inc. (NCMI) stock in a research note released on June 21, 2022, offered a Neutral rating with a price target of $1.50. Wedbush was of the view on November 04, 2021, that the stock is Outperform, while The Benchmark Company gave the stock a Buy rating on April 07, 2021. B. Riley Securities on their part issued a Buy rating on October 12, 2020.
